Nordin B E Christopher, WIshart Judith M, Clifton Peter M, McArthur Rosemary, Scopacasa Franca, Need Allan G, Morris Howard A, O'Loughlin Peter D, Horowitz Michael
Division of Clinical Biochemistry, Institute of Medical and Veterinary Science, Department of Medicine, University of Adelaide, Adelaide, Australia.
Clin Endocrinol (Oxf). 2004 Jul;61(1):123-30. doi: 10.1111/j.1365-2265.2004.02066.x.
To evaluate the effects of the menopause on bone-related biochemical variables in a longitudinal study.
Recruitment by advertisement of premenopausal women over the age of 44 for measurement of selected variables and collection of blood and urine samples for deep freezing, followed by annual check of menopausal status and repeat collection of blood and urine samples for deep freezing after the menopausal transition.
A total of 104 women with confirmed premenopausal status and on no treatment likely to affect calcium or bone metabolism were admitted to the study over a period of 2 years. After 8 years, 43 of the volunteers had passed through the menopause and the study was closed.
Radiocalcium absorption was measured at the first attendance and again after the menopausal transition. Calcium and other relevant variables were measured consecutively on paired thawed-out samples of blood and urine.
The data were complete in 34 subjects. In these women, there were highly significant correlations between the first and second measurements of most variables - serum calcium and fractions, radiocalcium absorption, vitamin D metabolites, PTH and others - indicating significant 'tracking' of these variables across the menopause. Within that framework there were significant rises in serum total and calculated ionized calcium (both P < 0.001) without change in mean serum parathyroid hormone (PTH). Radiocalcium absorption fell (P < 0.001) without change in serum 1,25D. There was a rise in fasting urinary calcium (P < 0.001) which could not be explained by the rise in filtered load and therefore represented a fall in TmCa (P < 0.001). There were significant rises in urinary bone resorption markers, pyridinoline and deoxypyridinoline (P < 0.001).
We conclude that the menopausal rise in calculated serum ionized calcium without fall in PTH, indicates a change in PTH set-point, and that the falls in gastrointestinal absorption and renal tubular reabsorption of calcium reflect the loss of an oestrogen action at these two sites. Although these changes are sufficient to explain the rise in calcium requirement at the menopause, the association of high bone resorption with normal serum PTH suggests also an increased sensitivity of bone to the action of parathyroid hormone. There is significant 'tracking' of many variables across the menopause despite very significant changes in their absolute values.
在一项纵向研究中评估绝经对骨相关生化指标的影响。
通过广告招募44岁以上的绝经前女性,测量选定变量并采集血液和尿液样本进行深度冷冻,随后每年检查绝经状态,并在绝经过渡期后再次采集血液和尿液样本进行深度冷冻。
在2年时间里,共有104名确诊为绝经前状态且未接受可能影响钙或骨代谢治疗的女性纳入研究。8年后,43名志愿者进入绝经状态,研究结束。
首次就诊时及绝经过渡期后再次测量放射性钙吸收。对配对解冻的血液和尿液样本连续测量钙及其他相关变量。
34名受试者数据完整。在这些女性中,大多数变量的首次和第二次测量之间存在高度显著相关性——血清钙及其组分、放射性钙吸收、维生素D代谢产物、甲状旁腺激素(PTH)等——表明这些变量在绝经过程中存在显著的“追踪”现象。在此框架内,血清总钙和计算得出的离子钙显著升高(均P<0.001),而血清甲状旁腺激素(PTH)均值无变化。放射性钙吸收下降(P<0.001),血清1,25D无变化。空腹尿钙升高(P<0.001),这无法用滤过负荷增加来解释,因此代表肾小管钙重吸收阈值(TmCa)下降(P<0.001)。尿骨吸收标志物吡啶啉和脱氧吡啶啉显著升高(P<0.001)。
我们得出结论,绝经后计算得出的血清离子钙升高而PTH不下降,表明PTH设定点发生变化,钙的胃肠道吸收和肾小管重吸收下降反映了雌激素在这两个部位作用的丧失。尽管这些变化足以解释绝经后钙需求的增加,但高骨吸收与正常血清PTH的关联也表明骨对甲状旁腺激素作用的敏感性增加。尽管许多变量的绝对值发生了非常显著的变化,但在绝经过程中仍存在显著的“追踪”现象。